Andere talen Botanix Pharmaceuticals Limited

Aandelen

BOT

AU000000BOT2

Beurs gesloten - Australian S.E. Andere beurzen 08:10:57 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,365 ^AUD	+5,80%		+8,96%	+92,11%

21/06	Botanix Pharmaceuticals haalt AU$70 miljoen op via institutionele plaatsing	MT
21/05	BOTANIX PHARMACEUTICALS LIMITED : Evans & Partners geeft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Botanix Pharmaceuticals to Raise AU$70 Million via Institutional Placement	21/06
Botanix Pharmaceuticals Secures US FDA Approval for Topical Medication	20/06
Botanix Pharmaceuticals Submits Last Label Materials for Sofdra FDA Approval	12/06
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index	18/03
Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
US FDA Accepts Resubmission of Botanix Pharmaceuticals' Topical Medication	22/01
Botanix Pharmaceuticals Completes US FDA Resubmission for Topical Medication; Shares Gain 3%	21/12
Botanix Pharmaceuticals Completes Human Factors Validation Study for Topical Medication; Shares Rise 3%	14/12
Botanix Pharmaceuticals Secures US FDA Feedback for Topical Medication	04/12
Botanix Pharmaceuticals Limited Receives Feedback from FDA	03/12
Botanix Pharmaceuticals Completes Nearly AU$14 Million Institutional Placement	01/12
Botanix Pharmaceuticals to Raise AU$13.5 Million in Placement; Shares Fall 3%	27/11
Acne Vulgaris Pipeline\| Clinical Trials, Key Companies - Novan, Bausch Health AOBiome, Ascletis Pharmaceuticals, AnaptysBio, Botanix Pharmaceuticals	07/11
Moderate to Severe Inflammatory Acne Vulgaris Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	27-10-23
Botanix Pharmaceuticals Signs Telehealth Deal for Dermatological Product	24-10-23
Botanix Pharmaceuticals Secures Conditional US FDA Clearance for Use of 'Sofra' Trade Name	17-10-23
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX Emerging Companies Index	18-09-23
Botanix Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Botanix Pharmaceuticals Promotes COO to CEO	25-08-23
Botanix Pharmaceuticals Limited Appoints Howie Mckibbon as Chief Executive Officer	25-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Botanix Pharmaceuticals Limited

Aandelen

BOT

AU000000BOT2

Andere talen

Filters